Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: A cost‐effectiveness analysis

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Hepatology

• Publication date

  2012-04-01

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1002/hep.25507PMID 22135042PMCID PMC3319334
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cost-effectiveness in health and medicine

  2016cited by this paper
• Driving Simulation Can Improve Insight into Impaired Driving Skills in Cirrhosis

  2012cited by this paper
• Screening for minimal hepatic encephalopathy in asymptomatic drivers with liver cirrhosis.

  2011influential reference
• Review article: the design of clinical trials in hepatic encephalopathy – an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement

  2011cited by this paper
• Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy.

  2011cited by this paper
• Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy.

  2011cited by this paper
• Rifaximin in the treatment of hepatic encephalopathy

  2011cited by this paper
• Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial.

  2011cited by this paper
• Rifaximin Improves Psychometric Performance and Health-Related Quality of Life in Patients With Minimal Hepatic Encephalopathy (The RIME Trial)

  2011influential reference
• Predictors of the recurrence of hepatic encephalopathy in lactulose‐treated patients

  2010cited by this paper
• Drug therapy: Rifaximin 1

  2010cited by this paper
• Improving the inhibitory control task to detect minimal hepatic encephalopathy.

  2010influential reference
• Rifaximin treatment in hepatic encephalopathy.

  2010cited by this paper
• Minimal hepatic encephalopathy is associated with motor vehicle crashes: The reality beyond the driving test

  2009cited by this paper
• Road traffic injuries: a major global public health crisis.

  2008cited by this paper
• Patients with minimal hepatic encephalopathy have poor insight into their driving skills.

  2008cited by this paper
• The demise of the pencil? New computer-assisted tests for minimal hepatic encephalopathy.

  2008cited by this paper
• Inhibitory control test for the diagnosis of minimal hepatic encephalopathy.

  2008cited by this paper
• The cost‐effectiveness and budget impact of competing therapies in hepatic encephalopathy – a decision analysis

  2007cited by this paper
• Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy.

  2007cited by this paper
• Navigation skill impairment: Another dimension of the driving difficulties in minimal hepatic encephalopathy

  2007cited by this paper
• Testing for minimal hepatic encephalopathy in the United States: An AASLD survey

  2007cited by this paper
• An algorithm for the management of hepatic encephalopathy

  2007influential reference
• Lactulose improves cognitive functions and health‐related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy

  2007cited by this paper
• Minimal Hepatic Encephalopathy: A Vehicle for Accidents and Traffic Violations

  2007cited by this paper
• Lactulose treatment for hepatic encephalopathy, gastrointestinal symptoms, and health‐related quality of life

  2007cited by this paper
• Gastrointestinal symptoms in patients with liver cirrhosis: Associations with nutritional status and health-related quality of life

  2006cited by this paper
• Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations.

  2005cited by this paper
• Minimal hepatic encephalopathy impairs fitness to drive

  2004cited by this paper
• Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998

  2002cited by this paper
• Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy

  2001influential reference
• CHRONIC LIVER DISEASES: EPIDEMIOLOGY, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis

  2001cited by this paper
• Neuropsychological characterization of hepatic encephalopathy.

  2001cited by this paper
• Efficacy of Lactulose in Cirrhotic Patients with Subclinical Hepatic Encephalopathy

  2000cited by this paper
• Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy

  1997cited by this paper
• Lactulose improves psychometric testing in cirrhotic patients with subclinical encephalopathy

  1997cited by this paper
• Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability

  1995cited by this paper
• Hepatic Encephalopathy: Management With Lactulose and Related Carbohydrates

  1988cited by this paper
• The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis.

  1986cited by this paper
• Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism.

  1978cited by this paper

• Hepatic encephalopathy: Part 4, driving in the UK

  2025cites this paper
• Chinese Consensus on Clinical Diagnosis and Management of Covert Hepatic Encephalopathy

  2025cites this paper
• Assessment of microstructural abnormalities in gray and white matter of minimal hepatic encephalopathy patients using diffusion kurtosis imaging and their associations with neurocognitive dysfunction

  2025cites this paper
• Portal hypertension: recommendations for diagnosis and treatment. Consensus document sponsored by the Spanish Association for the Study of the Liver (AEEH) and the Biomedical Research Network Center for Liver and Digestive Diseases (CIBERehd).

  2024cites this paper
• Psychometric hepatic encephalopathy score (PHES) – when, how, why, and why not: a guide for the unfamiliar

  2024cites this paper
• Hyperammonemia in adults - 2025. Practical recommendations

  2024cites this paper
• Portal hypertension: recommendations for diagnosis and treatment. Consensus document sponsored by the Spanish Association for the Study of the Liver (AEEH) and the Biomedical Research Network Centre for Liver and Digestive Diseases (CIBERehd).

  2024cites this paper
• Neuroinflammation alters GABAergic neurotransmission in hyperammonemia and hepatic encephalopathy, leading to motor incoordination. Mechanisms and therapeutic implications

  2024cites this paper
• Efficacy and Safety of Variable Treatment Options in the Prevention of Hepatic Encephalopathy: A Systematic Review and Network Meta-Analysis

  2024cites this paper
• The crucial role of risk factors when dealing with hepatic Encephalopathy

  2024cites this paper
• Bibliometrics and knowledge mapping of the pathogenesis of hepatic encephalopathy in patients with liver cirrhosis

  2024cites this paper
• Novel approaches in the medical management of compensated cirrhosis

  2024cites this paper
• A Prospective Multimodal Education Intervention for Providers Does Not Increase Hepatic Encephalopathy Treatment Rates

  2024cites this paper
• Hepatic Encephalopathy following Transjugular Intrahepatic Portosystemic Shunt Placement

  2023cites this paper
• The Prevalence of Minimal Hepatic Encephalopathy in an Outpatient Hepatology Clinic

  2023cites this paper
• Russian Consensus on “Hyperammonemia in Adults”: The 2021 Version (in English)

  2022cites this paper
• Motor learning dysfunction and its association with neurotransmitters and gut microbiota dysbiosis in hepatic encephalopathy mice

  2022cites this paper
• Minimal Hepatic Encephalopathy Affects Daily Life of Cirrhotic Patients: A Viewpoint on Clinical Consequences and Therapeutic Opportunities

  2022cites this paper
• Cost-Effectiveness of Rifaximin-α versus Lactulose for the Treatment of Recurrent Episodes of Overt Hepatic Encephalopathy: A Meta-Analysis

  2022cites this paper
• Utility of the MRI-VSRAD system in diagnosing hepatic encephalopathy and/or dementia

  2022cites this paper
• Current approaches to hepatic encephalopathy.

  2022cites this paper
• The Link between Gut Microbiota and Hepatic Encephalopathy

  2022cites this paper
• EncephalApp Stroop Test for covert hepatic encephalopathy screening in Tunisian cirrhotic patients

  2022cites this paper
• Aberrant stability of brain functional architecture in cirrhotic patients with minimal hepatic encephalopathy

  2022cites this paper
• Effect of L-carnitine on quality of life in covert hepatic encephalopathy: a randomized, double-blind, placebo-controlled study

  2022cites this paper
• Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis

  2021cites this paper
• Research Progress in the Diagnosis of Minimal Hepatic Encephalopathy

  2021cites this paper
• Diagnosis and Management of Hepatic Encephalopathy

  2021cites this paper
• Evaluation of cerebral dysfunction in patients with chronic kidney disease using neuropsychometric and neurophysiological tests

  2021cites this paper
• The Use of Rifaximin in Patients With Cirrhosis

  2021cites this paper
• [The Psychometric Score for Hepatic Encephalopathy and the Stroop EncephalApp in the diagnosis of covert hepatic encephalopathy in Cuba].

  2021influential citation
• Russian Consensus “Hyperammonemia in Adults” (Version 2021)

  2021cites this paper
• Long-Term Management: Modern Measures to Prevent Readmission in Patients with Hepatic Encephalopathy.

  2020cites this paper
• Comparative Efficacy of Treatment Options for Minimal Hepatic Encephalopathy: A Systematic Review & Network Meta-analysis.

  2020cites this paper
• KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications

  2020cites this paper
• Incidence and Bedside Predictors of the First Episode of Overt Hepatic Encephalopathy in Patients With Cirrhosis.

  2020cites this paper
• Early identification of hepatic encephalopathy improves outcomes.

  2020cites this paper
• Impaired brain function improved by l-carnitine in patients with cirrhosis: evaluation using near-infrared spectroscopy

  2020cites this paper
• Cost-Effectiveness of Rifaximin Treatment in Patients with Hepatic Encephalopathy

  2020cites this paper
• The Molar Ratio of Total Branched-chain Amino Acids to Tyrosine Predicts a Digit Symbol Test Abnormality in Cirrhotic Patients

  2020influential citation
• Efficacy of rifaximin in the different clinical scenarios of hepatic encephalopathy

  2020cites this paper
• Title Sleep Disturbances and Quality of Life in Patients After Living DonorLiver Transplantation

  2019cites this paper
• The psychomotor vigilance task: Role in the diagnosis of hepatic encephalopathy and relationship with driving ability.

  2019cites this paper
• Predicting Overt Hepatic Encephalopathy for the Population With Cirrhosis

  2019cites this paper
• Hepatic encephalopathy and traffic accidents: Vigilance is needed!

  2019cites this paper
• Advances in psychometric tests for screening minimal hepatic encephalopathy: From paper-and-pencil to computer-aided assessment.

  2019cites this paper
• Impaired brain glucose metabolism in cirrhosis without overt hepatic encephalopathy: a retrospective 18F-FDG PET/CT study

  2019cites this paper
• Zinc supplementation in patients with cirrhosis and hepatic encephalopathy: a systematic review and meta-analysis

  2019cites this paper
• Real‐world effects of long‐term rifaximin treatment for Japanese patients with hepatic encephalopathy

  2019cites this paper
• Hepatic Encephalopathy Challenges, Burden, and Diagnostic and Therapeutic Approach.

  2019cites this paper
• Incidence of and Risk Factors for Hepatic Encephalopathy in a Population‐Based Cohort of Americans With Cirrhosis

  2019cites this paper
• Minimal Hepatic Encephalopathy: Silent Tragedy

  2019cites this paper
• Efficacy of rifaximin in the different clinical scenarios of hepatic encephalopathy.

  2019cites this paper
• The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies

  2018cites this paper
• Toward Alignment in the Reporting of Economic Evaluations of Diagnostic Tests and Biomarkers: The AGREEDT Checklist

  2018cites this paper
• Diagnosis and management of hepatic encephalopathy.

  2018cites this paper
• Treatment Options for Covert Hepatic Encephalopathy

  2018cites this paper
• Adventures in Developing an App for Covert Hepatic Encephalopathy

  2017cites this paper
• Encefalopatía hepática mínima

  2017cites this paper
• Sarcopenia predicts minimal hepatic encephalopathy in patients with liver cirrhosis

  2017cites this paper
• Updating Neuropsychological Test System for the Elderly and Modern Touch Screen Tablet Society by Resetting of the Cut-off Values

  2017cites this paper
• Updating the neuropsychological test system in Japan for the elderly and in a modern touch screen tablet society by resetting the cut‐off values

  2017cites this paper
• The PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patients

  2017cites this paper
• Covert Hepatic Encephalopathy: Can My Patient Drive?

  2017cites this paper
• Hepatic encephalopathy

  2017cites this paper
• Driving Performance Among Patients with Cirrhosis Who Drove to Their Outpatient Hepatology Clinic Appointments.

  2016cites this paper
• Evaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions

  2016influential citation
• Screening for minimal hepatic encephalopathy in patients with cirrhosis by cirrhosis-related symptoms and a history of overt hepatic encephalopathy.

  2016cites this paper
• CURRENT APPROACH TO DIAGNOSIS AND TREATMENT FOR LIVER FAILURE (LITERATURE REVIEW)

  2016cites this paper
• Impacto biopsicossocial da encefalopatia hepática

  2016cites this paper
• Efficacy of Probiotic Therapy in Preventing Overt Hepatic Encephalopathy

  2016cites this paper
• Recent developments in the diagnosis and treatment of covert/minimal hepatic encephalopathy

  2016cites this paper
• Can Testing the Impact of Minimal Hepatic Encephalopathy on Driving Skills be Prolific to Translate Research to Real Life Clinical Medicine?

  2016cites this paper
• Minimal hepatic encephalopathy: A review.

  2016cites this paper
• Frontal assessment battery: A tool for screening minimal hepatic encephalopathy?

  2016cites this paper
• Correlation between the Degree of Liver Fibrosis and Driving Test Alterations as an Indicator of Minimal Hepatic Encephalopathy

  2015cites this paper
• Spontaneous portosystemic shunts in noncirrhotic patients presenting with encephalopathy

  2015cites this paper
• Management of covert hepatic encephalopathy.

  2015cites this paper
• Neuroinflammation and neurological alterations in chronic liver diseases

  2015cites this paper
• Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis.

  2015cites this paper
• Should We Treat Minimal/Covert Hepatic Encephalopathy, and with What?

  2015cites this paper
• Treatment of Overt Hepatic Encephalopathy.

  2015cites this paper
• Validation of EncephalApp, Smartphone-Based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy.

  2015cites this paper
• Covert and Overt Hepatic Encephalopathy: Current Options for Diagnosis and Treatment

  2015cites this paper
• Impact of minimal/covert hepatic encephalopathy on patients with cirrhosis

  2015cites this paper
• Primary Care Management of Hepatic Encephalopathy: A Common Cirrhosis Complication

  2015cites this paper
• What Is the ethical (Not Legal) responsibility of a physician to treat minimal hepatic encephalopathy and advise patients not to drive?

  2015cites this paper
• Diagnosing minimal hepatic encephalopathy: from the ivory tower to the real world.

  2015cites this paper
• Covert and Overt Hepatic Encephalopathy: Diagnosis and Management.

  2015cites this paper
• Primary Care Management of Hepatic Encephalopathy: A Common Cirrhosis

  2015cites this paper
• Legal Responsibilities of Physicians When They Diagnose Hepatic Encephalopathy.

  2015cites this paper
• Pathophysiology and management of hepatic encephalopathy 2014 update: Ammonia toxicity and hyponatremia

  2015cites this paper
• Role of local and distant functional connectivity density in the development of minimal hepatic encephalopathy

  2015cites this paper
• Safety, efficacy, and patient acceptability of rifaximin for hepatic encephalopathy

  2014cites this paper
• Management of hepatic encephalopathy in the hospital.

  2014cites this paper
• Chapter 36 – Monitoring and Care

  2014cites this paper
• Minimal hepatic encephalopathy in patients with liver cirrhosis: magnetic resonance spectroscopic brain findings versus neuropsychological changes.

  2014cites this paper
• Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver

  2014cites this paper
• Systematic review with meta‐analysis: the effects of rifaximin in hepatic encephalopathy

  2014cites this paper
• Optimal treatment of hepatic encephalopathy.

  2014cites this paper